Nordic Bioproducts Group, an Espoo-based biomaterials deeptech company originating from Aalto University, has received a strategic minority investment from Japan’s Oji Holdings Corporation. The investment will help scale its AaltoCell™ cellulose platform, focusing on industrial development and market readiness.
Finnish Nordic Bioproducts secures strategic investment from Oji to scale cellulose deeptech
January 21, 2026